Agenda 2026
|
|
|---|---|
| 8:00 am | REGISTRATION AND BREAKFAST |
| 8:25 am | Erle Robertson Ph.D., Vice Chair of Otorhinolaryngology–Head and Neck Surgery, Professor of Microbiology Perelman School of Medicine, University of Pennsylvania, PA. ♦ Opening Remarks |
| First Session | Moderator: Dr. Italo Tempera, Ph.D., Associate Professor, Wistar Institute, Philadelphia, PA. |
| 8:30 – 9:00 am | Dr. Robert Yarchoan, Ph.D., Chief, HIV & AIDS Malignancy Branch, CCR & Director, Office of HIV & AIDS Malignancy, NCI, Bethesda, M.D ♦ “Studies on the pathogenesis and treatment of KSHV-multicentric Castleman disease and KSHV-inflammatory cytokine syndrome (KICS)”. |
| 9:00 – 9:20 am | Dr. Yanming Du, Ph.D., Professor, Baruch S. Blumberg Institute, Doylestown, PA. ♦ ““A Liver-Targeted, Orally Bioavailable, Dihydroquinolizinone Bis-acid with In Vivo Efficacy Against Hepatitis A and B Viruses”. |
| 9:20 – 9:40 am | Dr. Rebecca Satterwhite, Ph.D., Postdoctoral fellow, Dr. Kathy Shair lab, UPMC Hillman Cancer Center, Pittsburgh, PA ♦ “Enhancing nasopharyngeal carcinoma risk assessment by integrating Epstein–Barr Virus genotyping and serology”. |
| 9:40 – 10:00 am | Dr. Lauren Hook, Ph.D., Research Assistant Professor, Harvey Friedman Lab, University of Pennsylvania, Philadelphia, PA. ♦ “HSV2 gC2/gD2/gE2 mRNA vaccine generates epitope-specific antibody responses to gC2 and gD2 that correlate with protection from genital lesions and latent infection”. |
| 10:00 – 10:20 am | COFFEE BREAK |
| Second session | Moderator: Dr. Harvey Friedman, M.D., Professor of Medicine, University of Pennsylvania, Philadelphia, PA. |
| 10:20 – 11:10 am | Dr. David M. Knipe, Ph.D., Higgins Professor of Microbiology and Molecular Genetics, Dept. of Microbiology, Blavatnik Institute Harvard Medical School, Boston, MA. ♦ Gertrude and Werner Henle Lectureship Keynote Speaker ♦ “Sensing of Viral and Host DNA in Virus-Infected Cells: A New Mechanism for Activating the cGAS Pathway”. |
| 11:10 – 11:30 am | Dr. Alexander Price, Ph.D., Assistant Professor, The Wistar Institute, Philadelphia, PA. ♦ “RNA Splicing Inhibition is a Novel Therapeutic for EBV-Driven Cancer”. |
| 11:30 – 11:50 pm | Dr. Julia Sutter, Ph.D., Postdoctoral Fellow, Dr. Ahmed Diab Lab, University of Pennsylvania, Philadelphia, PA ♦ "Therapeutically targeting genomic instability in HPV+ head and neck squamous cell carcinoma". |
| 11:50 – 12:10 pm | Dr. Dipanwita Mitra, Ph.D. Postdoctoral Fellow, Laurie T. Krug, Ph.D., lab, National Cancer Institute, NIH, Bethesda, MD ♦ "Vaccination with Replication and Latency Dead Murine Gammaherpesvirus Protects against Wild-Type Infection and Reactivation in Mice”. |
| 12:10 – 12:20 pm | ♦ In Memoriam of Bernard Roizman – Personal comments, slides, short stories welcome |
| 12:20 – 01:20 pm | LUNCH |
| Third session | Moderator: Dr. Ahmed Diab, Ph.D., Assistant Professor, University of Pennsylvania, Philadelphia, PA. |
| 1:20 – 1:50 pm | Dr. Micah Luftig, PhD, Professor, Duke University School of Medicine, Durham, NC. ♦ “Heterogeneous Outcomes of EBV Infection”. |
| 1:50 – 2:10 pm | Dr. Michael McIntosh, Ph.D., Associate Professor, Department of Pediatrics, University of Florida, FL. ♦ “Effects of the EBV Lytic Phase on the Host Cell Proteome”. |
| 2:10 – 2:30 pm | Ms. Mei-Ling Liber, Graduate Research Assistant, Prof Moriah L. Szpara Lab, Pennsylvania State University, University Park, PA. ♦ “Comparative genomics of acyclovir resistance genotypes in longitudinal samples from adults with drug-resistant and drug-susceptible herpes simplex virus 1 infections”. |
| 2:30 – 2:50 pm | Dr. Reuben Onwe, Graduate Student, Jennifer Moffat Lab, SUNY Upstate Medical University, Syracuse, NY. ♦ “Fixed nonsynonymous vaccine Oka mutations in IE62 drive varicella-zoster virus attenuation in human skin”. |
| 2:50 – 3:10 pm | Dr. Krystal Lum, Ph.D., Associate Research Scholar, Dr. Ileana M. Cristea lab, Princeton University, NJ. ♦ ““Integrative Organoid Proteomics to Decode Tumor Vulnerabilities to Viruses and Cell-Cell Responses in the Infection Microenvironment". |
| 3:10 – 3:30 pm | AFTERNOON BREAK |
| Final Session | Moderator: Dr. Laurie T. Krug, Ph.D., Stadtman Investigator, NCI CCR HAMB, National Institutes of Health, Bethesda, MD. |
| 3:30 – 4:00 pm | Dr. Jinhong Chang, M.D., Ph.D., Harvey Alter Chair Professor, Baruch S Blumberg Institute, Doylestown, PA ♦ “Translational Virology Driving Innovation in Yellow Fever Antiviral Therapeutics”. |
| 4:00 – 4:20 pm | Dr. Sumita Bhaduri-McIntosh, M.D., Ph.D., Professor, Dept. of Pediatrics, University of Florida, FL. ♦ “Harnessing the ubiquitin-proteasomal system to kill EBV+ lymphomas”. |
| 4:20 – 4:40 pm | Dr. Peace Park, Ph.D., Postdoctoral Fellow, Dr. Italo Tempera Lab, The Wistar Institute, Philadelphia, PA. ♦ “Mapping B Cell Vulnerability to EBV using CITE-seq”. |
| 4:40 – 5:00 pm | Dr. Tina Cairns, Ph.D., Staff Scientist, Dr. Gary Cohen Lab, University of Pennsylvania, Philadelphia, PA. ♦ “Antibody Responses over Time to Key Epitopes in HSV-2 gC, gD and gE Differ in Persons with Frequent vs Infrequent Genital Herpes Recurrences”. |
| 5:00 pm | RECEPTION |
Herpesvirus Symposium Agenda 2026